Found 16 matching trials
Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes
PHASE3The purpose of this study is to obtain information on efficacy and safety o...
Location
Chinese PLA General Hospital
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients
PHASE1The purpose of this study is to evaluate the pharmacodynamics (PD), pharmac...
Location
Multiple Locations
The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy
PHASE4The goal of this clinical trial is to learn if SGLT2 inhibitor Henggliflozi...
Location
Shanghai Jiaotong University School of Medicine, Xinhua Hospital
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes
PHASE4This trial is conducted in China. The purpose of the 24-week trial is to in...
Location
Multiple Locations
The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients
PHASE1The purpose of this study is to obtain information on PK/PD, efficacy and s...
Location
Chinese PLA General Hospital
Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease
PHASE2The objective of this study was to evaluate the efficacy of HRS-1780 tablet...
Location
General Hospital of Eastern Theater Command
The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers
PHASE1SHR3824 is a novel inhibitor of renal sodium-glucose cotransporter 2, allow...
Location
Shanghai Xuhui Central Hospital
The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients
PHASE1The purpose of this study is to evaluate the efficacy and safety of 3 diffe...
Location
Multiple Locations
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
NADiabetic kidney disease (DKD) is a serious complication of diabetes, and it...
Location
Multiple Locations
Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM
PHASE4The prevalence of metabolic dysfunction-associated steatotic liver disease ...
Location
Jiangsu province hospital of traditional chinese medicine